tiprankstipranks
MedAvail Holdings (MDVLQ)
OTHER OTC:MDVLQ
Holding MDVLQ?
Track your performance easily

MedAvail Holdings (MDVLQ) Stock Price & Analysis

161 Followers

MDVLQ Stock Chart & Stats


Financials

Annual

Ownership Overview

2.96%97.04%
Insiders
2.96% Other Institutional Investors
97.04% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

MDVLQ FAQ

What was MedAvail Holdings’s price range in the past 12 months?
MedAvail Holdings lowest stock price was $1.15 and its highest was $7.49 in the past 12 months.
    What is MedAvail Holdings’s market cap?
    Currently, no data Available
    When is MedAvail Holdings’s upcoming earnings report date?
    MedAvail Holdings’s upcoming earnings report date is Aug 08, 2024 which is 106 days ago.
      How were MedAvail Holdings’s earnings last quarter?
      Currently, no data Available
      Is MedAvail Holdings overvalued?
      According to Wall Street analysts MedAvail Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does MedAvail Holdings pay dividends?
        MedAvail Holdings does not currently pay dividends.
        What is MedAvail Holdings’s EPS estimate?
        MedAvail Holdings’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does MedAvail Holdings have?
        MedAvail Holdings has 1,613,911 shares outstanding.
          What happened to MedAvail Holdings’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of MedAvail Holdings?
          Among the largest hedge funds holding MedAvail Holdings’s share is Deerfield Management Company, LP. It holds MedAvail Holdings’s shares valued at N/A.
            ---

            MedAvail Holdings Stock Smart Score

            Company Description

            MedAvail Holdings

            MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of advanced nutrition products, functional foods, and other technologies aimed at maintaining or improving the health and performance of muscle tissue. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.
            ---

            MDVLQ Earnings Call

            Q1 2023
            0:00 / 0:00
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Mind Medicine
            ATAI Life Sciences
            SELLAS Life Sciences Group
            Biodesix
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis